Determinants of graft arteriosclerosis after heart transplantation

  • C. D. Scott
  • I. W. Colquhoun
  • K. Gould
  • J. Au
  • J. H. Dark
Conference paper


Accelerated graft coronary artery disease (TxCAD) is now the most common complication limitinglong-term survival after heart transplantation. This study examines its association with several potentially causative factors. The study population comprised all 73 transplants recipients at this centre between May 1985 and June 1989 who survived at least 2 years. Coronary angiography was performedin every patient at 2 years after transplantation and annually thereafter. All angiograms were retrospectively examined for any evidence of TxCAD. The number of rejection episodes and history of cytomegalovirus (CMV) infection were determined from patient records. Fasting serum triglycerides, and total and HDL cholesterol were measured at between 18 and 60 months after transplantation. Patients with advanced TxCAD (> 70% stenoses) had a mean of 1.4 ±1.4 rejection episodes in the first year compared with 0.5 ± 0.8 episodes in those without TxCAD (P < 0.05). The mean number of episodes in all patients with any evidence of TxCAD was0.8 ± 1.1 which was not significantly different from those without TxCAD. There were no association between exposure to CMV infection and TxCAD or between hyperlipidaemia and TxCAD. We concludethat frequent episodes of allograft rejection are associated with the development of advanced TxCAD.Hyperlipidaemia is not associated with the development of TxCAD in the first 5 years after transplantation. A history of exposure to CMV is not associated with TxCAD in our patients possibly because of our routine use of anti-CMV hyperimmune globulin in CMV-mismatched patients.

Key words

Heart transplantation Graft arteriosclerosis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Balk AHMM, Linden MVD, Meeter K, et al (1991) Is there a relation between transplant coronary artery disease and the occurrence of CMV infection (abstract). J Heart Lung Transplant 10: 188Google Scholar
  2. 2.
    Bieber CP, Hunt SA, Schwinn DA, et al (1981) Complications in long term survivors of cardiac transplantation. Transplant Proc 13:207–211PubMedGoogle Scholar
  3. 3.
    Billingham ME (1985) Diagnosis of cardiac rejection by endomyocardial biopsy. J Heart Transplant 1:25–30Google Scholar
  4. 4.
    Billingham ME (1989) Graft coronary disease: the lesions and the patients. Transplant Proc 21:3665–3666PubMedGoogle Scholar
  5. 5.
    Cerilli J, Brasile J, Sosa J, et al (1987) The role of autoantibody to vascular endothelial cell antigens in atherosclerosis and vascular disease. Transplant Proc 14 [Suppl 5]: 47–49Google Scholar
  6. 6.
    Eich D, Thompson JA, Ko D, et al (1991) Hypercholesterolaemia in long term survivors of heart transplantation: An early marker of accelerated coronary artery disease. J Heart Lung Transplant 10:45–49PubMedGoogle Scholar
  7. 7.
    Freeman R, Gould FK, McMaster A (1990) Management of CMV antibody negative patients undergoing cardiac transplantation. J Clin Pathol 43:373–376PubMedCrossRefGoogle Scholar
  8. 8.
    Gao SZ, Schroeder JS, Alderman EL, et al (1987) Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patient. Circulation 76 [Suppl 5]: 56–61Google Scholar
  9. 9.
    Gao SZ, Johnson D, Schroeder JS, et al (1988) Transplant coronary artery disease: histopathologic correlations with angiographic morphology (abstract). J Am Coll Cardiol 11:135AGoogle Scholar
  10. 10.
    Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE (1989) Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261:3561–3566PubMedCrossRefGoogle Scholar
  11. 11.
    Hess MJ, Hastillo A, Mohanakumar T, et al (1983) Accelerated atherosclerosis in cardiac transplantation: role of cytotoxic B-cell antibodies and hyperlipidaemia. Circulation 68 [Suppl 2]: 94–101Google Scholar
  12. 12.
    Johnson DE, Gao SZ, Schroeder JS, DeCampli W, Billingham ME (1989) The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Transplant 8:349–359PubMedGoogle Scholar
  13. 13.
    Kaplan EL, Meier P (1958) Nonparametric estimation for incomplete observations. Am Stat Assoc 10:457CrossRefGoogle Scholar
  14. 14.
    Lower RR, Stofer RC, Shumway NE (1961) Homovital transplantation of the heart. J Thorac Cardiovasc Surg 41:196–202PubMedGoogle Scholar
  15. 15.
    McDonald K, Rector TS, Braunlin EA, Kubo SH, Olivari MT (1989) Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol 64: 359–362PubMedCrossRefGoogle Scholar
  16. 16.
    Narrod J, Kormos R, Armitage J, et al (1989) Acute rejection and coronary artery disease in long term survivors of heart transplantation. J Heart Transplant 8:418–421PubMedGoogle Scholar
  17. 17.
    Pascoe EA, Barnhart GR, Carter WH, et al (1987) The prevalence of cardiac allograft arteriosclerosis. Transplantation 44: 838–839PubMedCrossRefGoogle Scholar
  18. 18.
    Rose EA, Smith CR, Petrossian GA, Barr ML, Reemtsma K (1989) Humoral immune responses after cardiac transplantation: correlation with fatal rejection and graft atherosclerosis. Surgery 106:203–207PubMedGoogle Scholar
  19. 19.
    Stovin PGI, Sharpies L, Hutter JA, Wallwork J, English TAH (1991) Some prognostic factors for the development of transplant related coronary artery disease in human cardiac allografts. J Heart Lung Transplant 10:38–44PubMedGoogle Scholar
  20. 20.
    Uretsky B, Murali S, Reddy S, et al (1987) Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation 76:827–834PubMedCrossRefGoogle Scholar
  21. 21.
    Yowell RL, Hammond EH, Bristow MR, Watson FS, Renlund DG, O’Connell JB (1988) Acute vascular rejection involving the major coronary arteries of a cardiac allograft. J Heart Transplant 7:191–197PubMedGoogle Scholar
  22. 22.
    Zusman DR, Stinson EB, Oyer PE, et al (1985) Determinants of accelerated graft atherosclerosis in conventional and cyclosporin treated heart transplant recipients (abstract). J Heart Transplant 4:587Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • C. D. Scott
    • 1
  • I. W. Colquhoun
    • 1
  • K. Gould
    • 1
  • J. Au
    • 1
  • J. H. Dark
    • 1
  1. 1.Cardiothoracic CentreFreeman HospitalNewcastle-upon-TyneUK

Personalised recommendations